What is SYGGF stock price today?

SYGGF (Synairgen plc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is SYGGF stock going up or down today?

SYGGF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SYGGF stock now?

The decision to buy SYGGF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SYGGF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SYGGF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SYGGF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if SYGGF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is SYGGF's P/E ratio?

P/E ratio data for SYGGF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is SYGGF's market cap?

SYGGF (Synairgen plc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is SYGGF's price to book ratio?

SYGGF trades at a price-to-book (P/B) ratio of 0.01, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does SYGGF pay dividends?

SYGGF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is SYGGF's dividend yield?

SYGGF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is SYGGF stock a good long-term investment?

SYGGF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SYGGF's revenue growth rate?

Revenue growth data for SYGGF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for SYGGF are available on our dashboard with complete income statement analysis.

What are the risks of investing in SYGGF?

Key risks for SYGGF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SYGGF compare to its competitors?

Compare SYGGF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SYGGF's performance and positioning.

What is SYGGF's stock price target for 2026?

Our AI model provides price targets for SYGGF based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about SYGGF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SYGGF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SYGGF's next earnings report?

SYGGF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SYGGF - Synairgen plc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Synairgen plc

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antiviral responses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

SYGGF Key Statistics

Market Cap

$0.11M

P/B Ratio

0.01

EPS

$-0.03

Employees

How SYGGF Compares to Peers

SYGGF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
SYGGF(This stock)	$110.27K	N/A	0%	0.0%	-
AMGNAmgen Inc	$187.71B	24.5	0%	0.2%	vs AMGN
GILDGilead Sciences	$173.48B	20.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.35B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.71B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.50B	20.5	-0%	0.1%	vs BIIB

Synairgen plc Company Information

Headquarters: Mailpoint 810, Southampton, United Kingdom, SO16 6YD, undefined
Website: www.synairgen.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 17, 2026 at 12:55 AM EDT

Ready to invest in SYGGF?

Commission-free trading available. Affiliate links.

Upcoming Events for SYGGF

Dashboard

Enter a ticker to analyze